Clinical Trial Update: A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D) [Phase 2]

View source ↗

Summary

A Phase 2 trial testing three doses of RVX-100 against placebo in irritable bowel syndrome with diarrhea (IBS-D) has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• RVX-100

Snippet

Sponsor: Revogenex, Inc. | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: SUSPENDED